Clinical trial
Short Course Terlipressin for Control of Acute Variceal Bleeding
NCT00369694 · Aga Khan University, Other · Completed
Key facts
| NCT number | NCT00369694 |
|---|---|
| Title | Short Course Terlipressin for Control of Acute Variceal Bleeding |
| Official title | Randomized Double Blind Dummy Controlled Trial Of 24 Versus 72 Hours Of Terlipressin As An Adjuvant Therapy In Acute Variceal Bleed |
| Lead sponsor | Aga Khan University, Other |
| Collaborators | Ferozsons Laboratories Ltd. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hemorrhage, Esophageal Varices, Portal Hypertension |
| Intervention type | Drug |
| Interventions | Terlipressin, Terlipressin & then Dummy |
| Enrollment | 130 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Aug 29, 2006 |
| Last update posted | Sep 25, 2008 |
| Countries | Pakistan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: